The prevalence of pulmonary hypertension (PH) complicating interstitial lung diseases
(ILDs) is 3.5–15% at an early stage, and up to 90% in ILD patients listed for lung …

Interstitial lung diseases (ILDs) may be complicated by the development of pulmonary
hypertension (PH), which is associated with worse functional impairment and a poorer …

Pulmonary hypertension (PH) is a common complication of interstitial lung diseases (ILDs),
particularly in idiopathic pulmonary fibrosis and ILD associated with connective tissue …

Interstitial lung disease-associated pulmonary hypertension... : Current Opinion in Pulmonary
Medicine Interstitial lung disease-associated pulmonary hypertension – what the future holds …

Background Pulmonary hypertension (PH) is a key complication in interstitial lung disease
(ILD), with recent therapeutic advances. Research question What are the diagnostic …

Pulmonary hypertension in interstitial lung disease: screeni... : Current Opinion in
Pulmonary Medicine Pulmonary hypertension in interstitial lung disease: screening …

Pulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases.
The presence of PH in the setting of underlying Interstitial Lung Disease (ILD) is strongly …

Pulmonary hypertension (PH) is present in an important proportion of patients with interstitial
lung diseases (ILDs), encompassing a large, heterogeneous group of diffuse parenchymal …

In the lungs, parenchymal and vascular remodelling share pathomechanisms that may
explain the relatively high prevalence (30–40%) of pulmonary hypertension (PH) in …

Pulmonary hypertension (PH) may complicate the course of many forms of advanced
interstitial lung disease (ILD) and has been shown to portend a worse outcome. The …